Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros

Base de datos
Tipo del documento
Intervalo de año
1.
Am Surg ; 88(5): 1016-1017, 2022 May.
Artículo en Inglés | MEDLINE | ID: covidwho-1741777

RESUMEN

Coronavirus disease 2019 (COVID-19) is linked with a hypercoagulable state called COVID-19-associated coagulopathy (CAC). Due to elevated levels of factor VIII and fibrinogen as well as inflammation-linked hyperviscosity of blood, the risk for venous thromboembolism is increased in patients who have CAC. We report the case of a patient with recent COVID-19 infection and no other past medical history who presented after a motorcycle collision with left middle and distal femur fractures, who underwent retrograde intramedullary nailing, and then developed immediate massive bilateral pulmonary emboli. The patient was treated with tissue plasminogen activator administration via bilateral pulmonary artery thrombolysis catheters without improvement, and was then placed on venoarterial extracorporeal membrane oxygenation for subsequent cardiogenic shock. During a 58-day hospital stay, the patient recovered and was discharged with a good long-term prognosis. In this report, we discuss CAC, the role of surgical critical care in the management of the disease, and issues specific to this patient's disease process and treatment.


Asunto(s)
Trastornos de la Coagulación Sanguínea , COVID-19 , Oxigenación por Membrana Extracorpórea , Trastornos de la Coagulación Sanguínea/etiología , Trastornos de la Coagulación Sanguínea/terapia , COVID-19/complicaciones , Oxigenación por Membrana Extracorpórea/efectos adversos , Humanos , Choque Cardiogénico/etiología , Activador de Tejido Plasminógeno
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA